Mitochondrial Proteome Changes in Rett Syndrome.

Area of Science:

• Neuroscience
• Genetics
• Biochemistry

Background:

• Rett syndrome (RTT) is a genetic neurodevelopmental disorder caused by mutations in the MECP2 gene.
• RTT pathology involves mitochondrial dysfunction, including increased mitochondrial content, oxidative stress, and altered ATP production.
• Understanding mitochondrial changes is crucial for defining RTT's pathogenic mechanisms.

Purpose of the Study:

• To investigate the comprehensive profile of mitochondrial proteins in a mouse model of RTT.
• To identify differentially expressed mitochondrial proteins in specific brain regions affected by RTT.

Main Methods:

• Comparative proteomics using two-dimensional gel electrophoresis and mass spectrometry.
• Analysis of mitochondrial proteins in the neocortex and hippocampus of symptomatic Mecp2-mutant mice.

Main Results:

• Identified differentially expressed mitochondrial proteins, including components of respiratory chain complexes I and III, and ATP synthase.
• Upregulation of specific NADH dehydrogenase subunits and cytochrome b-c1 complex subunit 1.
• Downregulation of regulatory mitochondrial proteins like mitofusin-1, HSP60, and 14-3-3 protein theta in the neocortex.

Conclusions:

• The study provides detailed insights into altered mitochondrial function and morphology in RTT.
• Demonstrated brain-region-specific changes in the mitochondrial proteome.
• Supports the involvement of a metabolic component in the pathophysiology of RTT.